Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

In vivo inhibition of angiogenesis and tumor growth by sulfamoylated derivatives of 2-methoxyestradiol, STX 140 and STX 641

Chander SK. et al, (2006), CANCER RESEARCH, 66

Inhibition of growth of tumors derived from MCF-7 cells and MCF-7 cells overexpressing steroid sulfatase by STX64 and STX213

Foster PA. et al, (2006), CANCER RESEARCH, 66

Novel Dual aromatase-steroid sulfatase inhibitors

Woo L. et al, (2006), CANCER RESEARCH, 66

Steroid sulfate transporters : Novel targets for breast cancer treatment.

Raobaikady B. et al, (2006), CANCER RESEARCH, 66

Sulphamoylated derivatives of 2-methoxyestradiol induce apoptosis in breast, ovarian and prostate cancer cell lines through mitotic arrest via the intrinsic apoptotic pathway

Ho YT. et al, (2006), CANCER RESEARCH, 66

The expanding roles of biocatalysis and biotransformation - Editorial overview

DeSantis G. and Davis BG., (2006), CURRENT OPINION IN CHEMICAL BIOLOGY, 10, 139 - 140

The role of 17 beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells.

Newman SP. et al, (2006), CANCER RESEARCH, 66

Endogenously bound calmodulin is essential for the function of the inositol 1,4,5-trisphosphate receptor.

Kasri NN. et al, (2006), J Biol Chem, 281, 8332 - 8338

Design and synthesis of 5'-deoxy-5'-phenyladenophostin A, a highly potent IP3 receptor ligand.

Mochizuki T. et al, (2006), Org Lett, 8, 1455 - 1458

Hippocampal long-term potentiation is supported by presynaptic and postsynaptic tyrosine receptor kinase B-mediated phospholipase Cgamma signaling.

Gärtner A. et al, (2006), J Neurosci, 26, 3496 - 3504

17Beta-hydroxysteroid dehydrogenase Type 1 and Type 2: association between mRNA expression and activity in cell lines.

Day JM. et al, (2006), Mol Cell Endocrinol, 248, 246 - 249

Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.

Su X. et al, (2006), Mol Cell Endocrinol, 248, 214 - 217

Novel, potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

Allan GM. et al, (2006), Mol Cell Endocrinol, 248, 204 - 207

The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancer.

Purohit A. et al, (2006), Mol Cell Endocrinol, 248, 199 - 203

Sugar and enzymes: Exploring and exploiting protein-carbohydrate interactions

Davis BG., (2006), ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 231

A systematic study of C-glucoside trisphosphates as myo-inositol trisphosphate receptor ligands. Synthesis of beta-C-glucoside trisphosphates based on the conformational restriction strategy.

Terauchi M. et al, (2006), J Med Chem, 49, 1900 - 1909

Structure of a flavonoid glucosyltransferase reveals the basis for plant natural product modification.

Offen W. et al, (2006), EMBO J, 25, 1396 - 1405

Fundamental importance of Na+-Ca2+ exchange for the pacemaking mechanism in guinea-pig sino-atrial node.

Sanders L. et al, (2006), J Physiol, 571, 639 - 649

Unusual entry to the novel 8-halo-N1-ribosyl hypoxanthine system by degradation of a cyclic adenosine-5'-diphosphate ribose analogue.

Moreau C. et al, (2006), Chem Commun (Camb), 1127 - 1129

NO can suppress myogenic tone in rat middle cerebral arteries by activating BKc.

McNeish AJ. et al, (2006), FASEB JOURNAL, 20, A1113 - A1113

Load More

«
...
129
130
131
132
133
134
135
...
»

Include forthcoming?